Viewing Study NCT06216158


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-06-13 @ 7:50 AM
Study NCT ID: NCT06216158
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2024-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Sponsor:
Organization: